Insys Therapeutics Competitors and Similar CompaniesClear all

Insys Therapeutics's competitors and similar companies include AstraZeneca and BeyondSpring.

	Insys Therapeutics Insys Therapeutics is a specialty pharmaceutical company that develops and commercializes innovative supportive care products.	AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.	BeyondSpring BeyondSpring (also known as Spring Pharmaceuticals) is a biopharmaceutical company focused on oncology therapies.
Founding Date	Founding Date 1998	Founding Date 1999	Founding Date 2010
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare biotech clinical research drug development oncology pharma
Locations	Locations Chandler, US HQ Chandler, US Round Rock, US	Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more	Locations Florham Park, US HQ
Employees	Employees 22634% decrease	Employees 94,300	Employees 4014% increase
Valuation ($)	Valuation ($) 3.1 m	Valuation ($) 2.7 b	Valuation ($) 89.4 m
Financial
Revenue (est.)	Revenue (est.) $82.1m (FY, 2018)	Revenue (est.) $58.7b (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods $10.8m (FY, 2018)	Cost of goods $4.9b (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit $71.3m (FY, 2018)	Gross profit $54.2b (FY, 2025)	Gross profit N/A
Net income	Net income ($124.5m) (FY, 2018)	Net income $10.2b (FY, 2025)	Net income ($16.7m) (FY, 2024)
Funding
Total funding raised	Total funding raised $ 2.3m	Total funding raised $ 1b	Total funding raised $ 36.1m